Podcast: The Secretome, Longevity Medicine And Alternatives To GLP-1 Agonists

Podcast: In Conversation With 2024 Rising Leader, Hanadie Yousef

One of In Vivo's 2024 Rising Leaders, Hanadie Yousef, CEO of Juvena Therapeutics, talks about the secretome as a source of therapeutics, the company's lead assets, the future of longevity medicine and learning as you go as a biotech entrepreneur.  

Hanadie Yousef, CEO of Juvena Therapeutics, is one of In Vivo's 2024 Rising Leaders. She co-founded Juvena based on the science of the secretome, the collection of proteins secreted by human stem cells. In this episode, Yousef explains the science behind the secretome, Juvena's platform, the company's lead assets and her experience as a young entrepreneur. 

Timestamps: 

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Rising Leaders

More from Leadership